China NMPA Product Recall - Bcl-6 antibody reagent (immunohistochemistry) Bond Ready-to-Use Primary Antibody Bcl-6 (LN22)
China NMPA product recall for Bcl-6 antibody reagent (immunohistochemistry) Bond Ready-to-Use Primary Antibody Bcl-6 (LN22) by Leica Biosystems Newcastle Ltd published December 16, 2022. Recall level: Level 3 Recall. Leica Biosystems Newcastle Ltd has initiated a voluntary Class III recall of its Bcl-6 antibody reag
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Bcl-6 antibody reagent (immunohistochemistry) Bond Ready-to-Use Primary Antibody Bcl-6 (LN22) by Leica Biosystems Newcastle Ltd published December 16, 2022. Recall level: Level 3 Recall. Leica Biosystems Newcastle Ltd has initiated a voluntary Class III recall of its Bcl-6 antibody reag
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox